Vogt-Koyanagi-Harada syndrome

Area of Science:

• Ophthalmology
• Immunology
• Rheumatology

Background:

• Vogt-Koyanagi-Harada (V-K-H) syndrome is an idiopathic multisystem inflammatory disease.
• The syndrome typically affects young adults and can lead to significant visual impairment.
• The role of corticosteroid therapy in modulating V-K-H syndrome presentation is not fully understood.

Purpose of the Study:

• To investigate the clinical characteristics and outcomes of Vogt-Koyanagi-Harada (V-K-H) syndrome in patients who developed the condition following corticosteroid therapy.
• To compare the severity and extraocular manifestations in this cohort with historical data from patients not treated with corticosteroids prior to V-K-H onset.

Main Methods:

• Retrospective analysis of 51 patients diagnosed with Vogt-Koyanagi-Harada (V-K-H) syndrome.
• Assessment of final visual acuity and documentation of extraocular manifestations.
• Comparison of clinical findings with pre-corticosteroid era V-K-H patient data.

Main Results:

• Final visual acuity better than 6/15 (20/50) was achieved in 50% of patients.
• 25% of patients experienced final visual acuity worse than 6/60 (20/200).
• The severity and frequency of extraocular manifestations appeared reduced compared to historical controls.

Conclusions:

• Corticosteroid therapy prior to or during the onset of Vogt-Koyanagi-Harada (V-K-H) syndrome may alter its clinical presentation.
• The observed differences could suggest a milder disease course or modified inflammatory response.
• Further research is needed to confirm these findings and explore potential mechanisms, considering the possibility of a skewed patient population.